Skip to main content
. 2021 Dec 15;11(12):e050804. doi: 10.1136/bmjopen-2021-050804

Table 1.

Adjusted difference in the mean of each group compared with the control group

6 Months P value 12 Months P value 18 Months P value 24 Months P value
Cognitive-attitudinal outcomes
Knowledge (DIATEK): F=47.3 P<0.001; ICC PHCP=0.06; ICC subject|PHCP=0.35
PTI 0.64 (0.17 to 1.11) 0.007 0.65 (0.2 to 1.11) 0.005
PFI −0.38 (−0.85 to 0.09) 0.11 −0.6 (−1.06 to −0.14) 0.01
CBI 0.63 (0.16 to 1.11) 0.008 0.34 (−0.12 to 0.8) 0.15
Empowerment (DES-SF): F=17.3 P<0.001; ICC PHCP=0.08; ICC; subject|PHCP=0.08
PTI 1.58 (−0.59 to 3.75) 0.15 3.04 (1.08 to 4.99) 0.002
PFI 3.95 (1.9 to 6) <0.001 1.84 (−0.11 to 3.79) 0.07
CBI 3.97 (1.9 to 6.04) <0.001 2.63 (0.68 to 4.58) 0.008
Behavioural outcomes
Adherence dietary recommendations (MEDAS): F=25.0 P<0.001; ICC PHCP=0.03; ICC subject|PHCP=0.20
PTI 0.22 (−0.25 to 0.69) 0.36 0.71 (0.17 to 1.24) 0.01 0.93 (0.46 to 1.41) <0.001 0.87 (0.4 to 1.35) <0.001
PFI −0.58 (−1.04 to −0.11) 0.01 −0.96 (−1.46 to −0.47) <0.001 0.17 (−0.31 to 0.64) 0.49 0.03 (−0.44 to 0.5) 0.90
CBI 0.44 (−0.03 to 0.91) 0.06 0.06 (−0.47 to 0.58) 0.83 0.88 (0.4 to 1.35) <0.001 0.7 (0.22 to 1.17) 0.004
Medication adherence (MGLS): F=14.4 P<0.001; ICC PHCP=0.04; ICC subject|PHCP=0.20
PTI 0.09 (−0.11 to 0.3) 0.37 0.09 (−0.12 to 0.3) 0.39 0.13 (−0.09 to 0.34) 0.24 0.16 (−0.04 to 0.36) 0.12
PFI 0.01 (−0.2 to 0.22) 0.90 −0.13 (−0.34 to 0.08) 0.24 −0.06 (−0.26 to 0.15) 0.58 0.09 (−0.11 to 0.3) 0.39
CBI 0.03 (−0.18 to 0.24) 0.77 −0.19 (−0.41 to 0.03) 0.08 0 (−0.21 to 0.21) 0.98 −0.1 (−0.31 to 0.11) 0.36
Affective outcomes
Depression (BDI-II): F=53.6 P<0.001; ICC PHCP=0.05; ICC subject|PHCP=0.34
PTI −1.91 (−3.99 to 0.17) 0.07 −0.76 (−2.68 to 1.16) 0.44
PFI −2.99 (−4.99 to −1) 0.003 0.37 (−1.56 to 2.3) 0.71
CBI −3 (−5.13 to −0.87) 0.006 0.23 (−1.73 to 2.19) 0.82
Anxiety (STAI-S): F=36.0 P<0.001; ICC PHCP=0.07 ICC; subject|PHCP=0.32
PTI −2.25 (−5.75 to 1.25) 0.21 −2.18 (−5.54 to 1.18) 0.20
PFI −3.47 (−6.95 to 0.02) 0.05 −0.39 (−3.78 to 2.99) 0.82
CBI −5.4 (−8.99 to −1.81) 0.003 −0.50 (−3.9 to 2.9) 0.77
Distress (DDS2): F=14.9 P<0.001; ICC PHCP=0.05 ICC; subject|PHCP=0.25
PTI −0.23 (−0.53 to 0.07) 0.13 −0.34 (−0.62 to −0.07) 0.01
PFI −0.24 (−0.53 to 0.05) 0.10 −0.31 (−0.58 to −0.04) 0.03
CBI −0.36 (−0.65 to −0.07) 0.01 −0.24 (−0.51 to 0.03) 0.08
Health-related quality of life and symptoms
Health-related quality of life (ADDQoL-19): F=25.3 P<0.001; ICC PHCP=0.04; ICC subject|PHCP=0.34
PTI 0.09 (−0.24 to 0.42) 0.60 0.40 (0.04 to 0.76) 0.03 0.39 (0.05 to 0.72) 0.02 0.16 (−0.17 to 0.48) 0.34
PFI −0.09 (−0.42 to 0.23) 0.56 0.51 (0.16 to 0.86) 0.005 −0.02 (−0.35 to 0.31) 0.89 −0.06 (−0.38 to 0.26) 0.71
CBI 0.03 (−0.3 to 0.35) 0.88 0.84 (0.49 to 1.18) <0.001 0.21 (−0.13 to 0.54) 0.23 −0.05 (−0.38 to 0.28) 0.77
Neuropathic symptom (MNSI): F=59.8 P<0.001; ICC PHCP=0.02 ICC; subject|PHCP=0.32
PTI −0.35 (−0.8 to 0.09) 0.12 −0.08 (−0.49 to 0.33) 0.70
PFI −0.42 (−0.87 to 0.03) 0.07 0.35 (−0.07 to 0.78) 0.11
CBI −0.57 (−1.04 to −0.1) 0.02 0.31 (−0.12 to 0.74) 0.16

The models were adjusted by the baseline value of dependent variables and time elapsed since diagnosis.

ADDQoL, Audit of Diabetes-Dependent Quality of life; BDI-II, Beck Depression Inventory II; CBI, combined intervention for patients and professionals; DDS2, Diabetes Distress Scale; DES-SF, Diabetes Empowerment Scale-Short Form; ICC, intraclass correlation coefficient; MEDAS, Mediterranean Diet Adherence Screener; MGLS, Morisky Medication Adherence Scale; MNSI, Michigan Neuropathy Screening Instrument; PFI, intervention only for healthcare professionals at primary care; PHCP, Primary Care Health Practices; PTI, intervention only for patients and family members; STAI-S, State Trait Anxiety Inventory.